Targeting Non-Coding RNAs for the Development of Novel Hepatocellular Carcinoma Therapeutic Approaches

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Hepatocellular carcinoma (HCC) is a major global health concern with poor patient prognosis despite recent therapeutic advancements.
• Novel therapeutic strategies are urgently needed to improve outcomes for HCC patients.
• Targeting molecules with tumor-specific expression offers a potential avenue for novel treatments.

Purpose of the Study:

• To review the therapeutic potential of targeting non-coding RNAs (ncRNAs) in Hepatocellular Carcinoma (HCC).
• To explore the roles of microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs) in HCC development and progression.
• To highlight current trends and opportunities in ncRNA-based HCC therapies.

Main Methods:

• Literature review focusing on ncRNAs in HCC.
• Analysis of the characteristics and functions of miRNAs, lncRNAs, and circRNAs in HCC.
• Examination of ncRNAs' involvement in HCC drug resistance and liver fibrosis.

Main Results:

• ncRNAs significantly regulate key HCC features such as proliferation, apoptosis, invasion, and metastasis.
• Specific ncRNAs show aberrant expression in HCC, making them potential therapeutic targets.
• ncRNAs are implicated in HCC drug resistance and the progression of liver fibrosis.

Conclusions:

• Targeting ncRNAs represents a promising therapeutic strategy for HCC.
• Further research into ncRNA mechanisms and therapeutic applications could lead to more effective HCC treatments.
• Understanding ncRNA roles in drug resistance and fibrosis is crucial for comprehensive HCC management.